These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9512079)
21. Effects of 5-HT1A and 5-HT2 receptor agonists on the behavioral and neurochemical consequences of repeated nicotine treatment. Olausson P; Akesson P; Engel JA; Söderpalm B Eur J Pharmacol; 2001 May; 420(1):45-54. PubMed ID: 11412838 [TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects of typical and atypical anxiolytics on learning in monkeys and rats. Winsauer PJ; Bixler MA; Mele PC J Pharmacol Exp Ther; 1996 Mar; 276(3):1111-27. PubMed ID: 8786542 [TBL] [Abstract][Full Text] [Related]
23. Fentanyl dose-sparing in polyarthritic rats requires full agonism at 5-HT Depoortere R; Bardin L; Newman-Tancredi A J Opioid Manag; 2024; 20(4):269-274. PubMed ID: 39321046 [TBL] [Abstract][Full Text] [Related]
24. Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists. Detke MJ; Wieland S; Lucki I Psychopharmacology (Berl); 1995 May; 119(1):47-54. PubMed ID: 7675949 [TBL] [Abstract][Full Text] [Related]
25. Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze. Zanoveli JM; Nogueira RL; Zangrossi H Eur J Pharmacol; 2003 Jul; 473(2-3):153-61. PubMed ID: 12892833 [TBL] [Abstract][Full Text] [Related]
26. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor. Tricklebank MD; Neill J; Kidd EJ; Fozard JR Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789 [TBL] [Abstract][Full Text] [Related]
27. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635. de Boer SF; Lesourd M; Mocaer E; Koolhaas JM J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850 [TBL] [Abstract][Full Text] [Related]
28. Effects of 5-HT agonists, selective for different receptor subtypes, on oxytocin, CCK, gastrin and somatostatin plasma levels in the rat. Uvnäs-Moberg K; Hillegaart V; Alster P; Ahlenius S Neuropharmacology; 1996; 35(11):1635-40. PubMed ID: 9025112 [TBL] [Abstract][Full Text] [Related]
29. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam. Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269 [TBL] [Abstract][Full Text] [Related]
30. The therapeutic efficacy conferred by the 5-HT(1A) receptor agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia. Kline AE; Massucci JL; Dixon CE; Zafonte RD; Bolinger BD J Neurotrauma; 2004 Feb; 21(2):175-85. PubMed ID: 15000758 [TBL] [Abstract][Full Text] [Related]
31. Intraseptal injection of the 5-HT1A/5-HT7 agonist 8-OH-DPAT and working memory in rats. Jeltsch H; Bertrand F; Galani R; Lazarus C; Schimchowitsch S; Cassel JC Psychopharmacology (Berl); 2004 Aug; 175(1):37-46. PubMed ID: 15014926 [TBL] [Abstract][Full Text] [Related]
32. Only repeated administration of the serotonergic agonist 8-OH-DPAT improves place learning of rats subjected to fimbria-fornix transection. Malá H; Arnberg K; Chu D; Nedergaard SK; Witmer J; Mogensen J Pharmacol Biochem Behav; 2013 Aug; 109():50-8. PubMed ID: 23680575 [TBL] [Abstract][Full Text] [Related]
33. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone. Protais P; Lesourd M; Comoy E Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353 [TBL] [Abstract][Full Text] [Related]
34. Buspirone raises blood pressure through activation of sympathetic nervous system and by direct activation of alpha1-adrenergic receptors after severe hemorrhage. Osei-Owusu P; Scrogin KE J Pharmacol Exp Ther; 2004 Jun; 309(3):1132-40. PubMed ID: 14769835 [TBL] [Abstract][Full Text] [Related]
35. Effects of 8-OH-DPAT, a 5-HT1A receptor agonist, and DOI, a 5-HT2A/2C agonist, on monosynaptic transmission in spinalized rats. Hasegawa Y; Ono H Brain Res; 1996 Oct; 738(1):158-61. PubMed ID: 8949941 [TBL] [Abstract][Full Text] [Related]
36. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain. Tilakaratne N; Friedman E Eur J Pharmacol; 1996 Jun; 307(2):211-7. PubMed ID: 8832223 [TBL] [Abstract][Full Text] [Related]
37. Effect of selective serotonin agonists on basal, corticotrophin-releasing hormone- and vasopressin-induced ACTH release in vitro from rat pituitary cells. Calogero AE; Bagdy G; Moncada ML; D'Agata R J Endocrinol; 1993 Mar; 136(3):381-7. PubMed ID: 8386213 [TBL] [Abstract][Full Text] [Related]
38. Combined treatment with a 5HT1A receptor agonist and a muscarinic acetylcholine receptor antagonist disrupts water maze navigation behavior. Riekkinen M; Sirviö J; Toivanen T; Riekkinen P Psychopharmacology (Berl); 1995 Nov; 122(2):137-46. PubMed ID: 8848529 [TBL] [Abstract][Full Text] [Related]
39. Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation. Chojnacka-Wójcik E Pol J Pharmacol Pharm; 1992; 44(5):427-36. PubMed ID: 1363616 [TBL] [Abstract][Full Text] [Related]
40. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat. Bervoets K; Millan MJ; Colpaert FC Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]